CONTRACTILITY IN EXPERIMENTAL VOLUME OVERLOAD

实验体积过载中的收缩性

基本信息

  • 批准号:
    3354266
  • 负责人:
  • 金额:
    $ 10.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-03-01 至 1993-02-28
  • 项目状态:
    已结题

项目摘要

Prolonged left ventricular volume overload in man results in reduced contractile function and poor pump performance. The mechanisms leading to contractile dysfunction are difficult to study in man because of obvious ethical constraints and because few patients are ever followed from the onset of their volume overload through the period of compensated eccentric hypertrophy to the point of ventricular dysfunction. Experimental models of volume overload would be useful in studying the mechanisms of ventricular dysfunction that occur but unfortunately these models usually do not produce left ventricular dysfunction. Thus, models of right ventricular volume overload (which are probably not germane to left ventricular volume overload) have not produced a contractile deficit . Left ventricular models which have used complete heart block or various AV fistulas have usually demonstrated normal contractiles function although one such model did demonstrate a contractile deficit. In this proposal we will study contractile function in pure volume overload as produced by a unique closed chest model of mitral regurgitation. We will use the mean velocity of circumferential fiber shortening-stress relationship, which is relatively load independent, to assess contractile function longitudinally as volume overload hypertrophy develops. Pilot data using this model suggests that in fact a contractile deficit does occur. IF A CONTRACTILE DEFICIT DOES OCCUR, WE WILL ATTEMPT TO ASCERTAIN WHETHER THE DEFICIT IS A PROPERTY OF THE ABNORMAL CHAMBER GEOMETRY PRODUCED BY VOLUME OVERLOAD OR DUE TO INTRINSIC MYOCARDIAL CELLULAR DYSFUNCTION. On a more clinical level it is obvious that mitral valve replacement results in a fall in pump performance postoperatively. This diminution in performance ranges from mild to severe but almost always occurs and is usually irreversible. While the traditional explanation for this fall in pump performance is that it is due to increased afterload due to removal of the low impedence pathway into the left atrium this point is controversial. In this proposal we will perform mitral valve replacement in chronic mitral regurgitation. We will then examine in a systematic fashion 1) reduced contractile performance, 2) increased afterload, 3) inability of additional hypertrophy to offset the increased afterload, and 4) removal of the papillary mitral complex as possible mechanisms for the postoperative fall in performance seen following mitral value replacement.
长时间的左心室容量超载会导致

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BLASE A CARABELLO其他文献

BLASE A CARABELLO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BLASE A CARABELLO', 18)}}的其他基金

UPGRADE OF ANGIOGRAPHIC FACILITY
血管造影设施升级
  • 批准号:
    3521123
  • 财政年份:
    1991
  • 资助金额:
    $ 10.89万
  • 项目类别:
CONTRACTILITY IN EXPERIMENTAL VOLUME OVERLOAD
实验体积过载中的收缩性
  • 批准号:
    3354270
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
BETA BLOCKADE IN MITRAL REGURGITATION
β 阻断治疗二尖瓣反流
  • 批准号:
    2218733
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
BETA BLOCKADE IN MITRAL REGURGITATION
β 阻断治疗二尖瓣反流
  • 批准号:
    2218731
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
CONTRACTILITY IN EXPERIMENTAL VOLUME OVERLOAD
实验体积过载中的收缩性
  • 批准号:
    3354268
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
BETA BLOCKADE IN MITRAL REGURGITATION
β 阻断治疗二尖瓣反流
  • 批准号:
    2028292
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
CONTRACTILITY IN EXPERIMENTAL VOLUME OVERLOAD
实验体积过载中的收缩性
  • 批准号:
    3354271
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
CONTRACTILITY IN EXPERIMENTAL VOLUME OVERLOAD
实验体积过载中的收缩性
  • 批准号:
    3354269
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
BETA BLOCKADE IN MITRAL REGURGITATION
β 阻断治疗二尖瓣反流
  • 批准号:
    2218732
  • 财政年份:
    1988
  • 资助金额:
    $ 10.89万
  • 项目类别:
CORONARY BLOOD FLOW IN SUB CORONARY AORTIC STENOSIS
冠状动脉瓣下狭窄的冠状动脉血流
  • 批准号:
    3352302
  • 财政年份:
    1985
  • 资助金额:
    $ 10.89万
  • 项目类别:

相似海外基金

Wearable devices for reducing congestive heart failure hospitalizations
可减少充血性心力衰竭住院次数的可穿戴设备
  • 批准号:
    568003-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 10.89万
  • 项目类别:
    Postdoctoral Fellowships
Remote ischemic preconditioning for renal and cardiac protection in congestive heart failure (RICH) trial
充血性心力衰竭 (RICH) 试验中远程缺血预处理对肾脏和心脏的保护
  • 批准号:
    10426064
  • 财政年份:
    2021
  • 资助金额:
    $ 10.89万
  • 项目类别:
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
SGLT2 抑制对充血性心力衰竭有益作用的新靶点机制(肾神经)
  • 批准号:
    10669642
  • 财政年份:
    2021
  • 资助金额:
    $ 10.89万
  • 项目类别:
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
SGLT2 抑制对充血性心力衰竭有益作用的新靶点机制(肾神经)
  • 批准号:
    10472675
  • 财政年份:
    2021
  • 资助金额:
    $ 10.89万
  • 项目类别:
Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failure
SGLT2 抑制对充血性心力衰竭有益作用的新靶点机制(肾神经)
  • 批准号:
    10275320
  • 财政年份:
    2021
  • 资助金额:
    $ 10.89万
  • 项目类别:
I-Corps: Machine Learning based Clinical Decision Support Tool to Predict 30-day Hospital Readmissions for Congestive Heart Failure Patients
I-Corps:基于机器学习的临床决策支持工具,可预测充血性心力衰竭患者 30 天再入院情况
  • 批准号:
    2039546
  • 财政年份:
    2020
  • 资助金额:
    $ 10.89万
  • 项目类别:
    Standard Grant
Development of therapeutic strategy against congestive heart failure by food ingredients.
通过食品成分开发针对充血性心力衰竭的治疗策略。
  • 批准号:
    20K05918
  • 财政年份:
    2020
  • 资助金额:
    $ 10.89万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Stress and Congestive Heart Failure: A mechanistic clinical trial
压力和充血性心力衰竭:机械临床试验
  • 批准号:
    10657561
  • 财政年份:
    2020
  • 资助金额:
    $ 10.89万
  • 项目类别:
Stress and Congestive Heart Failure: A mechanistic clinical trial
压力和充血性心力衰竭:机械临床试验
  • 批准号:
    10200143
  • 财政年份:
    2020
  • 资助金额:
    $ 10.89万
  • 项目类别:
Stress and Congestive Heart Failure: A mechanistic clinical trial
压力和充血性心力衰竭:机械临床试验
  • 批准号:
    10452504
  • 财政年份:
    2020
  • 资助金额:
    $ 10.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了